FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’

Roche has been given a green light by the FDA to use one of its diagnostic tests to identify coronavirus patients at risk of developing a severe inflammatory response – and may benefit from treatment with one of its drugs.